Market cap
$153 Mln
Recently Viewed
Clear All$22.71
$12.63
(125.30%)
As on 29-Jul-2022 16:00EDT
Market cap
$153 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.8
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-6 Mln
ROE
-33.5 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-52.2
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
6,746,090
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Brookline Capital Acquisition Corp (BCAC)
| 126.9 | 123.3 | 124.4 | 130.8 | -- | -- | -- |
|
BSE Sensex*
| -8.3 | 4.2 | -5.6 | -2.4 | 9.2 | 10.1 | 11.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Brookline Capital Acquisition Corp (BCAC)
|
22.7 | 153.2 | 0.0 | -3.7 | -- | -- | -- | 2.8 |
| 73.9 | 9,733.6 | 1,091.0 | 202.3 | 31.6 | 31.3 | 43.4 | 17.1 | |
| 66.3 | 8,216.2 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 46.9 | 11,658.3 | 2,320.1 | 782.6 | 39.0 | 35.5 | 16.1 | 5.3 | |
| 89.6 | 11,852.6 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 68.4 | 8,209.1 | 1,396.6 | 316.9 | 59.8 | 153.6 | 27.1 | 161.7 | |
| 529.1 | 12,204.5 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 20.3 | |
| 508.5 | 14,867.3 | 2,530.2 | 451.1 | 21.3 | 70.2 | 34 | 32.4 | |
| 108.9 | 8,460.0 | 0.0 | -425.4 | -- | -36.7 | -- | 6.8 | |
| 337.3 | 9,538.9 | 0.0 | -303.3 | -- | -45.8 | -- | 10.9 |
Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one... or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York. Read more
Chairman & CEO
Dr. Samuel P. Wertheimer Ph.D.
Chairman & CEO
Dr. Samuel P. Wertheimer Ph.D.
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Brookline Capital Acquisition Corp (BCAC) is $22.71 (NASDAQ) as of 29-Jul-2022 16:00 EDT. Brookline Capital Acquisition Corp (BCAC) has given a return of 130.79% in the last 1 years.
Since, TTM earnings of Brookline Capital Acquisition Corp (BCAC) is negative, P/E ratio is not available.
The P/B ratio of Brookline Capital Acquisition Corp (BCAC) is 2.75 times as on 29-Jul-2022, a 40 discount to its peers’ median range of 4.57 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of Brookline Capital Acquisition Corp (BCAC) are Rs -- and Rs -- as of 23-Apr-2026.
Brookline Capital Acquisition Corp (BCAC) has a market capitalisation of $ 153 Mln as on 29-Jul-2022. As per SEBI classification, it is a company.
Before investing in Brookline Capital Acquisition Corp (BCAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.